Clear Perspectives Financial Planning, LLC Citius Pharmaceuticals, Inc. Transaction History
Clear Perspectives Financial Planning, LLC
- $178 Million
- Q1 2023
A detailed history of Clear Perspectives Financial Planning, LLC transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Clear Perspectives Financial Planning, LLC holds 400 shares of CTXR stock, worth $272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$272
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CTXR
# of Institutions
73Shares Held
26.8MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY8.73MShares$5.93 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.01MShares$4.76 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$2 Million0.0% of portfolio
-
State Street Corp Boston, MA2.21MShares$1.5 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL1.12MShares$761,7960.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $99.4M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...